Dr. Lilia Rizo Topete MexicoHospital Universitario "José Eleuterio Gonzá

Internal Medicine and Critical NephrologynAcademic training:nGeneral Medicine: School of Medicine of the Tecnológico de Monterrey, ITESM.nInternal Medicine: Christus Muguerza High Specialty, UDEM.nNephrology, "José Eleuterio González" University Hospital. UANL.nCritical Nephrology, International Renal Research Institute of Vicenza, Italy, IRRIV.nMaster of Education at TecMilenionNowadays:nProfessor Attached to the Department of Internal Medicine of the University Hospital "José eleuterio González", UANLnProfessor attached to the Nephrology service "José eleuterio González" University Hospital, UANL.nFull Professor of the Internal Medicine Service Hospital Christus Muguerza Alta EspecialidadnClinical Professor at the Tec de Monterrey School of MedicinenMember of the National System of ResearchersnMember of the College of Internal Medicine of MexiconMember of the College of Nephrologists of MexiconMember of the Mexican Institute of Nephrology ResearchnMember of the SLANH IRA committee.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	AKI and Critical Care Nephrology in Latin America - By the ISN Young Nephrologists Committee YN JavierNeyra Chairperson jneyra@uabmc.eduUnited StatesUniversity of Alabama at Birmingham SabineKaram Chairperson United StatesUniversity of Minnesota CELLULAR PRION PROTEIN ATTENUATES RENAL FIBROSIS BY INTERACTING WITH TSPAN7 TO INDUCE FORMATION OF MIGRASOME. YN Best Abstract Winner - Basic Science WeizeChen Free Communication 20111210015@fudan.edu.cnChina Assessing Baseline Cardiovascular Disease for Kids Initiating Kidney Replacement Therapy: ABCD4Kids study. YN Best Abstract Winners - Clinical Science PriyankaKhandelwal Free Communication drpriyanka8588@gmail.comIndia Blood Purification in Low Resource Settings: What is the Evidence and How Can It Be Implemented? ThiagoDe Azevedo Reis Speaker thiagoreisnefro@gmail.comBrazilHospital Sírio-Libanês, São Paulo, Brazil & Fenix Novel Concepts of AKI Sub-phenotyping and Augmented Clinical Decision Support for AKI Care VicenteCampolo Girard Speaker vmcampolo@icloud.comArgentinaUniversidad de Buenos Aires Roundtable: Implementation, Challenges and Pipeline of Development and Sustainability of Critical Care Nephrology Programs in Latin America Dario XavierJimenez Acosta Speaker dxjimenezmd@gmail.comEcuadorUniversity Quito-Ecuador, Enrique Garcés Hospital Dr. Lilia Rizo Topete Speaker lilia.rizo@udem.eduMexicoHospital Universitario "José Eleuterio Gonzá KrissiaWallbach-Massai Speaker krissia.wallbach@gmail.comBrazil Mariano RafaelFarias Speaker marianofarias20@hotmail.comArgentinaDr. Hall C3
12:15 p.m. 1:15 p.m.	Onconephrology: Various Flavors of AKI CHAL02 JavierDe Arteaga Chairperson javierdearteaga@gmail.comArgentinaHospital Privado Universitario de Cordoba. Catholic University from Cordoba KarinaSoto Chairperson ksoto.nefro@gmail.comPortugalCentro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de Lisboa SandraHerrmann Chairperson herrmann.sandra@mayo.eduUnited StatesMayo Clinic AKI-related Cancer and Cancer Treatment-related TMA ClaraGarcía Carro Speaker claragarciacarro@hotmail.comSpainSan Carlos Clinical Hospital (Madrid, Spain) AKI Related to Cancer Immunotherapy: Can Biomarkers Help? SebastianLapman Speaker lapseba@yahoo.com.arArgentina Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland Q and A Hall E
3 p.m. 4 p.m.	Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment IK01 FelipeInserra Chairperson felipe.inserra@gmail.comArgentina YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine New Insights into the Mechanisms of Kidney Injury in the CRS WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States Novel Pharmacological Treatments of the CRS MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center Device-related Treatment for CRS ClaudioRonco Speaker cronco@goldnet.itItalyInternational Renal Research Institute of Vicenza Q and A Hall D